It also suggested that caution should be taken when making a diagnosis between MS and NMOSD, and one should carefully integrate the history and the clinical symptoms and signs together with CSF analysis, neuroimaging, and serological testing of AQP4-IgG, MOG-IgG, and oAIA before drawing a conclusion. The gene discussed is AQP4; the disease is myeloid sarcoma.